Lerman C - Search Results

1

Molecular genetics of successful smoking cessation: convergent genome-wide association study results.

Uhl GR, Liu QR, Drgon T, Johnson C, Walther D, Rose JE, David SP, Niaura R, Lerman C. Uhl GR, et al. Among authors: lerman c. Arch Gen Psychiatry. 2008 Jun;65(6):683-93. doi: 10.1001/archpsyc.65.6.683. Arch Gen Psychiatry. 2008. PMID: 18519826 Free PMC article. Clinical Trial.

2

Attention-Deficit Hyperactivity Disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program.

Lerman C, Audrain J, Tercyak K, Hawk LW Jr, Bush A, Crystal-Mansour S, Rose C, Niaura R, Epstein LH. Lerman C, et al. Nicotine Tob Res. 2001 Nov;3(4):353-9. doi: 10.1080/14622200110072156. Nicotine Tob Res. 2001. PMID: 11694203 Clinical Trial.

3

Mediating mechanisms for the impact of bupropion in smoking cessation treatment.

Lerman C, Roth D, Kaufmann V, Audrain J, Hawk L, Liu A, Niaura R, Epstein L. Lerman C, et al. Drug Alcohol Depend. 2002 Jul 1;67(2):219-23. doi: 10.1016/s0376-8716(02)00067-4. Drug Alcohol Depend. 2002. PMID: 12095672 Clinical Trial.

4

Pharmacogenetic investigation of smoking cessation treatment.

Lerman C, Shields PG, Wileyto EP, Audrain J, Pinto A, Hawk L, Krishnan S, Niaura R, Epstein L. Lerman C, et al. Pharmacogenetics. 2002 Nov;12(8):627-34. doi: 10.1097/00008571-200211000-00007. Pharmacogenetics. 2002. PMID: 12439223 Clinical Trial.

5

Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial.

Lerman C, Shields PG, Wileyto EP, Audrain J, Hawk LH Jr, Pinto A, Kucharski S, Krishnan S, Niaura R, Epstein LH. Lerman C, et al. Health Psychol. 2003 Sep;22(5):541-8. doi: 10.1037/0278-6133.22.5.541. Health Psychol. 2003. PMID: 14570538 Clinical Trial.

6

Effect of bupropion on depression symptoms in a smoking cessation clinical trial.

Lerman C, Niaura R, Collins BN, Wileyto P, Audrain-McGovern J, Pinto A, Hawk L, Epstein LH. Lerman C, et al. Psychol Addict Behav. 2004 Dec;18(4):362-6. doi: 10.1037/0893-164X.18.4.362. Psychol Addict Behav. 2004. PMID: 15631608 Clinical Trial.

7

Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials.

Lerman C, Jepson C, Wileyto EP, Epstein LH, Rukstalis M, Patterson F, Kaufmann V, Restine S, Hawk L, Niaura R, Berrettini W. Lerman C, et al. Neuropsychopharmacology. 2006 Jan;31(1):231-42. doi: 10.1038/sj.npp.1300861. Neuropsychopharmacology. 2006. PMID: 16123753 Clinical Trial.

8

Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence.

Berrettini WH, Wileyto EP, Epstein L, Restine S, Hawk L, Shields P, Niaura R, Lerman C. Berrettini WH, et al. Among authors: lerman c. Biol Psychiatry. 2007 Jan 1;61(1):111-8. doi: 10.1016/j.biopsych.2006.04.030. Epub 2006 Jul 28. Biol Psychiatry. 2007. PMID: 16876132 Clinical Trial.

9

Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation.

David SP, Brown RA, Papandonatos GD, Kahler CW, Lloyd-Richardson EE, Munafò MR, Shields PG, Lerman C, Strong D, McCaffery J, Niaura R. David SP, et al. Among authors: lerman c. Nicotine Tob Res. 2007 Aug;9(8):821-33. doi: 10.1080/14622200701382033. Nicotine Tob Res. 2007. PMID: 17654295 Free PMC article. Clinical Trial.

10

CHRNA4 and tobacco dependence: from gene regulation to treatment outcome.

Hutchison KE, Allen DL, Filbey FM, Jepson C, Lerman C, Benowitz NL, Stitzel J, Bryan A, McGeary J, Haughey HM. Hutchison KE, et al. Among authors: lerman c. Arch Gen Psychiatry. 2007 Sep;64(9):1078-86. doi: 10.1001/archpsyc.64.9.1078. Arch Gen Psychiatry. 2007. PMID: 17768273

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

429 results

Search Page